Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women.
van Kruijsdijk RC, Visseren FL, Ridker PM, Dorresteijn JA, Buring JE, van der Graaf Y, Cook NR. van Kruijsdijk RC, et al. Among authors: van der graaf y. Heart. 2015 Mar;101(5):369-76. doi: 10.1136/heartjnl-2014-306342. Epub 2014 Dec 4. Heart. 2015. PMID: 25475110 Free PMC article. Clinical Trial.
Obesity and cancer: the role of dysfunctional adipose tissue.
van Kruijsdijk RC, van der Wall E, Visseren FL. van Kruijsdijk RC, et al. Among authors: van der wall e. Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78. doi: 10.1158/1055-9965.EPI-09-0372. Epub 2009 Sep 15. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19755644 Review.
[Competing risks in clinical research].
van Kruijsdijk RC, Eijkemans MJ, Visseren FL. van Kruijsdijk RC, et al. Ned Tijdschr Geneeskd. 2012;156(46):A5176. Ned Tijdschr Geneeskd. 2012. PMID: 23151330 Review. Dutch.
Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome.
van Kruijsdijk RC, van der Graaf Y, Peeters PH, Visseren FL; Second Manifestations of ARTerial disease (SMART) study group. van Kruijsdijk RC, et al. Among authors: van der graaf y. Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1267-77. doi: 10.1158/1055-9965.EPI-13-0090. Epub 2013 May 15. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23677576
Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction.
van Kruijsdijk RC, Visseren FL, Boni L, Groen HJ, Dingemans AM, Aerts JG, van der Graaf Y, Ardizzoni A, Smit EF. van Kruijsdijk RC, et al. Ann Oncol. 2016 Jul;27(7):1280-6. doi: 10.1093/annonc/mdw154. Epub 2016 Apr 6. Ann Oncol. 2016. PMID: 27052652 Free article. Clinical Trial.
Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction.
van Kruijsdijk RCM, Vernooij RWM, Bots ML, Peters SAE, Dorresteijn JAN, Visseren FLJ, Blankestijn PJ, Debray TPA; HDF Pooling Project investigators. van Kruijsdijk RCM, et al. Clin Kidney J. 2022 Jun 20;15(10):1924-1931. doi: 10.1093/ckj/sfac153. eCollection 2022 Oct. Clin Kidney J. 2022. PMID: 36158156 Free PMC article.
Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer.
Kwakman JJM, van Kruijsdijk RCM, Elias SG, Seymour MT, Meade AM, Visseren FLJ, Punt CJA, Koopman M. Kwakman JJM, et al. Among authors: van kruijsdijk rcm. Acta Oncol. 2019 Mar;58(3):326-333. doi: 10.1080/0284186X.2018.1564840. Epub 2019 Jan 18. Acta Oncol. 2019. PMID: 30657353 Free article. Clinical Trial.
16 results